| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.35 | 1e-14 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |